Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider.
Front Immunol
; 11: 2069, 2020.
Article
in En
| MEDLINE
| ID: mdl-32973815
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Pulmonary Fibrosis
/
Severity of Illness Index
/
Coronavirus Infections
/
Galectin 3
/
Molecular Targeted Therapy
/
Betacoronavirus
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Front Immunol
Year:
2020
Document type:
Article
Affiliation country:
Spain
Country of publication:
Switzerland